Cargando…
Chronic airflow limitation in developing countries: burden and priorities
Respiratory disease has never received priority in relation to its impact on health. Estimated DALYs lost in 2002 were 12% globally (similar for industrialized and developing countries). Chronic airflow limitation (due mainly to asthma and COPD) alone affects more than 100 million persons in the wor...
Autores principales: | Aït-Khaled, Nadia, Enarson, Donald A, Ottmani, Salah, Sony, Asma El, Eltigani, Mai, Sepulveda, Ricardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695613/ https://www.ncbi.nlm.nih.gov/pubmed/18044686 |
Ejemplares similares
-
Combination therapy for airflow limitation in COPD
por: Ghanei, Mostafa, et al.
Publicado: (2012) -
Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
por: Pirozzi, Cheryl S., et al.
Publicado: (2018) -
Impact of airflow limitation in chronic heart failure
por: Bektas, S., et al.
Publicado: (2017) -
Extracellular adenosine triphosphate is associated with airflow limitation severity and symptoms burden in patients with chronic obstructive pulmonary disease
por: Hlapčić, Iva, et al.
Publicado: (2019) -
Testing limits to airflow perturbation device (APD) measurements
por: Lopresti, Erika R, et al.
Publicado: (2008)